A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site.
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2016
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Carboplatin; Paclitaxel
- Indications Cancer
- Focus Therapeutic Use
- 07 Jul 2016 Status changed from active, no longer recruiting to completed.
- 21 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 09 Apr 2014 Planned End Date changed from 1 Aug 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.